Alitretinoin. A new treatment option for chronic refractory hand eczema;Alitretinoin. Die erste spezifisch zugelassene therapie für das chronische handekzem

Hautarzt

Volumn 59, Issue 9, 2008, Pages 703-709

  Molin, S ^a   Ruzicka, T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

9 cis retinoic acid; Alitretinoin; Hand eczema; Panagonist; Randomized controlled trial

Indexed keywords

ALITRETINOIN; RETINOIC ACID RECEPTOR; STEROID;

ARTICLE; CLINICAL TRIAL; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; HAND ECZEMA; HUMAN; KERATINOCYTE;

ANTI-INFECTIVE AGENTS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; DERMATOLOGIC AGENTS; ECZEMA; HAND DERMATOSES; HUMANS; RECURRENCE; TREATMENT OUTCOME; TRETINOIN;

EID: 51349123397     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-008-1559-2     Document Type: Article

References (16)

1. Bollag 1999 Dermatology 199 308
2. Cheng 2008 Expert Opin Investig Drugs 17 437
3. Coenraads 2007 J Invest Dermatol 127 1568
4. Coenraads 2005 Br J Dermatol 152 296
5. Diepgen 2007 Contact Dermatitis 57 203
6. Held 2005 Br J Dermatol 152 302
7. Lerbaek 2007 J Invest Dermatol 127 1632
8. Lerbaek 2007 Br J Dermatol 157 552
9. Lerbaek 2008 Contact Dermatitis 58 210
10. Meding 1990 Contact Dermatitis 23 6
11. Meding 2007 J Invest Dermatol 127 2147
12. Rueff 2007 MMW Fortschr Med 149 31
13. Ruzicka 2004 Arch Dermatol 140 1453
14. Ruzicka 2008 Br J Dermatol 158 808
15. Thestrup-Pedersen 2001 Acta Derm Venereol 81 353
16. Van 2004 Br J Dermatol 151 446